Increased motility and suppression of ex vivo-expanded regulatory T cells designed for adoptive transfer therapy in ulcerative colitis
We sequenced non-expanded and expanded Human regulatory T cells. Cells were expanded over the course of 21 days using our previously published GMP-compliant Treg expansion protocol. Overall design: Differential expression analysis of non-expanded versus expanded regulatory T cells.